Abstract
Benefits of cardiovascular disease (CVD) risk factors control are well known, but goals achievement remains low. The objective of this study is to evaluate the prevalence of CVD risk factors among men ina worker's cohort with no previous CVD, to study control variations across time and the factors associated with poor control. To this end, we conducted a cohort reexamination (2010-2014) within the context of the Aragon Workers Health Study (AWHS). Data from working characteristics, analytical values and pharmacological prescription were included in the analysis. Prevalences of risk factor diagnosis and control were calculated, as well as factors associated with poor control. The prevalence of CVD risk factors was high. In 2014dyslipidaemia was the most prevalent (85.2%) followed by Hypertension (HT) (42.0%). People under treatment increased for the period analysed (p<0.001). The proportion of people treated varied from 72.2% in Diabetes Mellitus to 31.1% in dyslipidaemia in 2014. 46.2% of the workers with HT were controlled, decreasing to 21.9% in Diabetes and 11.0% in dyslipidaemia (2014). Working in a turn different to central shift was associated with poor control, especially for those working at night with HT (Odds Ratio in...Continue Reading
References
Jun 9, 1999·Scandinavian Journal of Work, Environment & Health·H Bøggild, A Knutsson
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Mar 29, 2005·Diabetes Care·Robert RatnerUNKNOWN Diabetes Prevention Program Research Group
Jan 12, 2007·British Journal of Clinical Pharmacology·Marie-Hélène BouchardSylvie Perreault
Apr 2, 2008·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Gaston GodinMarc Germain
Mar 17, 2009·Lancet·Kornelia KotsevaUNKNOWN EUROASPIRE Study Group
May 26, 2009·Lancet·Kausik K RayNaveed Sattar
Oct 7, 2009·Circulation·Giampiero MazzagliaLorenzo G Mantovani
Apr 8, 2011·European Heart Journal·José R BanegasFernando Rodríguez-Artalejo
Apr 20, 2011·European Journal of Preventive Cardiology·Jean DallongevilleUNKNOWN EURIKA Investigators
Sep 20, 2011·BMC Public Health·Eliseo GuallarFernando Rodríguez-Artalejo
Oct 12, 2011·Diabetologia·F SoriguerJ Vendrell
May 5, 2012·European Heart Journal·Joep PerkUNKNOWN ESC Committee for Practice Guidelines (CPG)
Jun 21, 2012·BMC Cardiovascular Disorders·José A CasasnovasValentín Fuster
Jul 4, 2012·The American Journal of Medicine·Sayed H NaderiDavid S Wald
Jul 28, 2012·BMJ : British Medical Journal·Manav V VyasDaniel G Hackam
Sep 6, 2012·Hypertension·José R BanegasFernando Rodríguez-Artalejo
May 3, 2013·PloS One·Beatriz Navarro-VidalAuxiliadora Graciani
Aug 3, 2013·European Heart Journal·Rajiv ChowdhuryOscar H Franco
Jul 2, 2014·Scandinavian Journal of Work, Environment & Health·Sarah E Neil-SztramkoCarolyn C Gotay
Aug 27, 2015·European Heart Journal·Nick TownsendMike Rayner
Nov 10, 2015·The New England Journal of Medicine·UNKNOWN SPRINT Research GroupWalter T Ambrosius
Jun 30, 2016·European Journal of Preventive Cardiology·UNKNOWN Authors/Task Force MembersJose Luis Zamorano
Jan 27, 2017·BMC Health Services Research·Annie QuickKate E Pickett
Citations
Mar 22, 2020·Medicina·Gediminas UrbonasKarolis Vencevičius
Jul 10, 2020·BMC Cardiovascular Disorders·Yu-Shan RenJie Li
Feb 6, 2020·PloS One·Isabel Aguilar-PalacioEliseo Guallar
Sep 30, 2020·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·J S RosalesS F Ameriso
Oct 24, 2020·International Journal of Environmental Research and Public Health·Isabel Aguilar-PalacioSara Malo
Dec 3, 2020·Journal of Clinical Medicine·Armando Chaure-PardosIsabel Aguilar-Palacio
Apr 4, 2021·Journal of Clinical Medicine·Isabel Aguilar-PalacioJosé Antonio Casasnovas
Oct 17, 2020·Molecular Biology Reports·Thaysa Walléria de Aragão SantosDanyelly Bruneska Gondim Martins